<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="5000">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03465280</url>
  </required_header>
  <id_info>
    <org_study_id>08733</org_study_id>
    <nct_id>NCT03465280</nct_id>
  </id_info>
  <brief_title>Airway Intervention Registry (AIR): Recurrent Respiratory Papillomatosis (RRP)</brief_title>
  <acronym>AIR:RRP</acronym>
  <official_title>Airway Intervention Registry (AIR) Extension: Recurrent Respiratory Papillomatosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Newcastle-upon-Tyne Hospitals NHS Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Alder Hey Children's NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute for Health Research, United Kingdom</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Newcastle-upon-Tyne Hospitals NHS Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Recurrent Respiratory Papillomatosis (RRP) causes wart-like growths in the airway which can&#xD;
      make it difficult to breathe, speak and carry out normal everyday activities. It is a rare&#xD;
      condition affecting all ages, but is more common and aggressive in children than in adults,&#xD;
      affecting 4 in every 100,000 children. There is no known cure for RRP, but symptoms are&#xD;
      checked through regular hospital visits, with multiple therapies or procedures under general&#xD;
      anaesthetic needed to remove or shrink the growths which can grow back quickly. The problem&#xD;
      is that nobody knows which therapies or procedures work best. Aim: To identify which RRP&#xD;
      treatments currently used in National Health Service (NHS) hospitals within the United&#xD;
      Kingdom (UK) are the most effective and safest in the short- and long-term. It will also&#xD;
      identify which patients respond best to specific treatments, and those who are at higher risk&#xD;
      of experiencing a complication after treatment.&#xD;
&#xD;
      Method: Collect information from usual patient care and quality of life questionnaire&#xD;
      responses in a secure online database. Participation in this study requires&#xD;
      patient/parent/guardian consent. This observational study does not require patients to&#xD;
      undergo any additional intervention as part of the research.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary aim:&#xD;
&#xD;
      The overall goal is to improve the care of patients with Recurrent Respiratory Papillomatosis&#xD;
      (RRP) - and the investigators aim to do this by determining the most effective and safe RRP&#xD;
      treatments currently being used in patients in National Health Service (NHS) hospitals within&#xD;
      the United Kingdom (UK) (information which is currently lacking).&#xD;
&#xD;
      By determining the most effective treatments of RRP, the investigators will be able to&#xD;
      increase the time interval between surgical interventions to maintain symptomatic control,&#xD;
      reduce overall number of RRP interventions, severity and spread of papillomas in the airway,&#xD;
      hospital visits, medications and ultimately improve quality of life in those suffering from&#xD;
      RRP. By also capturing peri- and post-procedural details the investigators will be able to&#xD;
      determine the relative safety of treatments and identify those which slow the progression of&#xD;
      disease.&#xD;
&#xD;
      From the data collected the investigators intend to identify patient subgroups (based on&#xD;
      patient characteristics such as age, gender, human papillomavirus (HPV) type, location of&#xD;
      papillomas, RRP severity and spread, comorbidities) who respond better to specific&#xD;
      treatments, and also identify patient risk factors which contribute to the complication&#xD;
      outcomes (such as tracheostomy).&#xD;
&#xD;
      Secondary aims:&#xD;
&#xD;
        -  build an evidence base of the different RRP treatments used across the UK which will&#xD;
           help to formulate hypotheses for future research in RRP and improve quality of life for&#xD;
           RRP patients;&#xD;
&#xD;
        -  inform National Institute for Health and Care Excellence (NICE) interventional procedure&#xD;
           guidance on radiofrequency cold ablation (IPG434,2012), which is currently under special&#xD;
           arrangements due to lack of safety and efficacy evidence;&#xD;
&#xD;
        -  identify common symptoms or signs associated with RRP disease profile, to aid future&#xD;
           diagnosis of RRP;&#xD;
&#xD;
        -  determine the geographical spread of RRP patients across the UK, to inform effective use&#xD;
           of future NHS resources and inform the Department of Health strategy in its quadrivalent&#xD;
           HPV vaccination programme (protecting against four types of HPV including types 6 and 11&#xD;
           commonly associated with RRP) currently offered to 12-13 year old girls within the NHS&#xD;
           childhood vaccination programme;&#xD;
&#xD;
        -  inform future development of national clinical guidance on management of RRP to ensure&#xD;
           that everyone receives the best care based on best available current knowledge;&#xD;
&#xD;
        -  determine impact of COVID on RRP patients including changes to RRP management, RRP&#xD;
           symptoms.&#xD;
&#xD;
      Objectives:&#xD;
&#xD;
      The investigators will make use of an existing secure online database platform (the Airway&#xD;
      Intervention Registry, AIR - developed and hosted by The Newcastle upon Tyne Hospitals NHS&#xD;
      Foundation Trust, NUTH) and its associated infrastructure and develop it to capture&#xD;
      additional observational outcomes from standard clinical practice and quality of life&#xD;
      questionnaires from RRP patients. All RRP patients (any age) receiving treatment in any UK&#xD;
      NHS hospital will be eligible for inclusion. Data collection will be open for 41 months with&#xD;
      no minimum follow-up required for patients. Due to its recurrent nature (requiring regular&#xD;
      hospital visits to maintain an open airway), following this patient population will allow the&#xD;
      investigators to determine both the short- and long-term relative safety and efficacy of RRP&#xD;
      treatments used in the UK. Consent will be required (from patients/parent/guardian) before&#xD;
      data are entered into the online database.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2018</start_date>
  <completion_date type="Anticipated">August 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>41 Months</target_duration>
  <primary_outcome>
    <measure>Time interval between surgical interventions</measure>
    <time_frame>Over study duration (41 months)</time_frame>
    <description>Time between surgical interventions to maintain symptomatic control</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>RRP surgical intervention - nature</measure>
    <time_frame>Over study duration (41 months)</time_frame>
    <description>Nature of intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>RRP surgical intervention - timing</measure>
    <time_frame>Over study duration (41 months)</time_frame>
    <description>Timing of intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>RRP adjuvant therapy - nature</measure>
    <time_frame>Over study duration (41 months)</time_frame>
    <description>Nature of intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>RRP adjuvant therapy - timing</measure>
    <time_frame>Over study duration (41 months)</time_frame>
    <description>Timing of intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Histology results</measure>
    <time_frame>Over study duration (41 months)</time_frame>
    <description>Including HPV type</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severity of papillomas</measure>
    <time_frame>Over study duration (41 months)</time_frame>
    <description>Measured via Derkay severity score (higher score corresponding with higher severity; clinical score range 0-11, anatomical score range 0-75, summed total score range 0-86)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of hospital visits/attendances</measure>
    <time_frame>Over study duration (41 months)</time_frame>
    <description>Inpatient, Accident &amp; emergency, Outpatient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Voice assessment (paediatric)</measure>
    <time_frame>Over study duration (41 months)</time_frame>
    <description>Measured via paediatric voice handicap index (higher score corresponding with higher voice handicap, range 0-99)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Voice assessment (adult)</measure>
    <time_frame>Over study duration (41 months)</time_frame>
    <description>Measured via voice handicap index (higher score corresponding with higher voice handicap, range 0-120)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Short-term complications</measure>
    <time_frame>During hospital admission for RRP intervention (length of hospital stay can vary between patients e.g. from 0-100 days)</time_frame>
    <description>Complications arising in-hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative discharge location - planned</measure>
    <time_frame>During hospital admission for RRP intervention (length of hospital stay can vary between patients e.g. from 0-100 days)</time_frame>
    <description>Planned discharge location (decided pre-operation)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative discharge location - actual</measure>
    <time_frame>During hospital admission for RRP intervention (length of hospital stay can vary between patients e.g. from 0-100 days)</time_frame>
    <description>Actual discharge location (occurring post-operation)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Long-term complications</measure>
    <time_frame>Over study duration (41 months)</time_frame>
    <description>Unexpected hospital, Accident &amp; emergency (A&amp;E), General Practitioner (GP) attendances due to RRP symptoms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Impact of COVID</measure>
    <time_frame>From March 2020 onwards (18 months)</time_frame>
    <description>Test results, antibody results, symptoms, changes to management,</description>
  </secondary_outcome>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Recurrent Respiratory Papillomatosis</condition>
  <condition>Human Papilloma Virus</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Microdebrider</intervention_name>
    <description>Removal of lesions via microdebrider</description>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cold-steel surgery (forceps)</intervention_name>
    <description>Removal of lesions via forceps</description>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Carbon dioxide laser</intervention_name>
    <description>Removal of lesions via carbon dioxide laser</description>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Potassium titanyl phosphate (KTP) laser</intervention_name>
    <description>Removal of lesions via KTP laser</description>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pulsed dye laser</intervention_name>
    <description>Removal of lesions via pulsed dye laser</description>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Radiofrequency ablation</intervention_name>
    <description>Removal of lesions via radiofrequency ablation</description>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Monopolar suction diathermy</intervention_name>
    <description>Removal of lesions via monopolar suction diathermy</description>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Plasma coagulation</intervention_name>
    <description>Removal of lesions via plasma coagulation</description>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Other</intervention_name>
    <description>Removal of lesions via other methods</description>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Adjuvant therapies</intervention_name>
    <description>All adjuvant therapies</description>
    <other_name>Acyclovir</other_name>
    <other_name>Artemisinin</other_name>
    <other_name>Bevacizumab (Avastin)</other_name>
    <other_name>Celecoxib (Celebrex)</other_name>
    <other_name>Cidofovir</other_name>
    <other_name>Cimetidine</other_name>
    <other_name>Di-indolmethane (DIM)</other_name>
    <other_name>Gardasil</other_name>
    <other_name>Indole-3-carbinol (I3C)</other_name>
    <other_name>alpha-Interferon</other_name>
    <other_name>PEG-Interferon</other_name>
    <other_name>Methotrexate</other_name>
    <other_name>Retinoic acid (isotretinoin)</other_name>
    <other_name>Ribavarin</other_name>
    <other_name>Other</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with respiratory papillomatosis receiving hospital treatment&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients of any age (no restrictions) diagnosed with (newly diagnosed or existing) and&#xD;
             receiving treatment for respiratory papillomatosis&#xD;
&#xD;
          -  informed assent/consent of data participation provided by patient/parent/guardian&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients participating in other studies&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adam Donne</last_name>
    <role>Principal Investigator</role>
    <affiliation>Alder Hey Children's NHS Foundation Trust</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andrew Sims</last_name>
    <phone>0191 244 8738</phone>
    <email>nuth.NMPCE.Air@nhs.net</email>
  </overall_contact>
  <location>
    <facility>
      <name>NHS Grampian</name>
      <address>
        <city>Aberdeen</city>
        <zip>AB25 2ZB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Betsi Cadwaladr University Health Board,</name>
      <address>
        <city>Bangor</city>
        <zip>LL57 2PW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Basildon &amp; Thurrock University Hospitals NHS FT</name>
      <address>
        <city>Basildon</city>
        <zip>SS165NL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Belfast Health and Social Care Trust</name>
      <address>
        <city>Belfast</city>
        <zip>BT2 8BG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Hospital Birmingham NHS Foundation Trust</name>
      <address>
        <city>Birmingham</city>
        <zip>B15 2GW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Birmingham Women's and Children's NHS Foundation Trust</name>
      <address>
        <city>Birmingham</city>
        <zip>B4 6NH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Blackpool Teaching Hospital NHS FT</name>
      <address>
        <city>Blackpool</city>
        <zip>FY38NR</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Bradford Teaching Hospitals NHS Foundation Trust</name>
      <address>
        <city>Bradford</city>
        <zip>BD9 6RJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Cambridge University Hospitals NHS Foundation Trust</name>
      <address>
        <city>Cambridge</city>
        <zip>CB2 0QQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Cardiff and Vale University Local Health Board</name>
      <address>
        <city>Cardiff</city>
        <zip>CF14 4XW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>North Cumbria Univeristy Hospital NHS Trust</name>
      <address>
        <city>Carlisle</city>
        <zip>CA27HY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hywel Dda University Health Board</name>
      <address>
        <city>Carmarthen</city>
        <zip>SA31 3BB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>County Durham and Darlington NHS Foundation Trust</name>
      <address>
        <city>Darlington</city>
        <zip>DL36HX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Hospitals of Derby and Burton NHS Foundation Trust</name>
      <address>
        <city>Derby</city>
        <zip>DE223NE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust</name>
      <address>
        <city>Doncaster</city>
        <zip>DN2 5LT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>NHS Tayside</name>
      <address>
        <city>Dundee</city>
        <zip>DD2 1GZ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>NHS Lothian</name>
      <address>
        <city>Edinburgh</city>
        <zip>EH16 4TJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Frimley Health NHS Foundation Trust</name>
      <address>
        <city>Frimley</city>
        <zip>GU16 7UJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>NHS Greater Glasgow &amp; Clyde</name>
      <address>
        <city>Glasgow</city>
        <zip>G120XH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>London North West University Healthcare NHS Trust</name>
      <address>
        <city>Harrow</city>
        <zip>HA1 3UJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Leeds Teaching Hospitals NHS Trust</name>
      <address>
        <city>Leeds</city>
        <zip>LS9 7TF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Alder Hey Children's NHS Foundation Trust</name>
      <address>
        <city>Liverpool</city>
        <zip>L12 2AP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Liverpool University Hospitals NHS Foundation Trust</name>
      <address>
        <city>Liverpool</city>
        <zip>L7 8XP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Barts Health NHS Trust</name>
      <address>
        <city>London</city>
        <zip>E1 2ES</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University College London Hospitals NHS Foundation Trust</name>
      <address>
        <city>London</city>
        <zip>NW1 2PG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Lewisham and Greenwich NHS Trust</name>
      <address>
        <city>London</city>
        <zip>SE13 6LH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>St George's University Hospitals NHS Foundation Trust</name>
      <address>
        <city>London</city>
        <zip>SW17 0QT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Imperial College Healthcare NHS Trust</name>
      <address>
        <city>London</city>
        <zip>W2 1NY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Great Ormond Street Hospital for Children NHS FT</name>
      <address>
        <city>London</city>
        <zip>WC1N3JH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Bedfordshire Hospitals NHS Foundation Trust</name>
      <address>
        <city>Luton</city>
        <zip>LU4 0DZ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Manchester University Hospital NHS Foundation Trust</name>
      <address>
        <city>Manchester</city>
        <zip>M13 9WL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Pennine Acute Hospitals NHS Trust</name>
      <address>
        <city>Manchester</city>
        <zip>M8 5RB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>South Tees Hospitals NHS Foundation Trust</name>
      <address>
        <city>Middlesbrough</city>
        <zip>TS4 3BW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Newcastle upon Tyne Hospitals NHS Foundation Trust</name>
      <address>
        <city>Newcastle Upon Tyne</city>
        <zip>NE7 7DN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrew Sims</last_name>
      <email>nuth.NMPCE.Air@nhs.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Isle of Wight NHS Trust</name>
      <address>
        <city>Newport</city>
        <zip>PO30 5TG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Nottingham University Hospitals NHS Trust</name>
      <address>
        <city>Nottingham</city>
        <zip>NG51PB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Oxford University Hospitals NHS Foundation Trust</name>
      <address>
        <city>Oxford</city>
        <zip>OX3 9DU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Hospital of Plymouth NHS Trust</name>
      <address>
        <city>Plymouth</city>
        <zip>PL6 8DH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Swansea Bay University Health Board</name>
      <address>
        <city>Port Talbot</city>
        <zip>SA12 7BR</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>East Sussex Healthcare NHS Trust</name>
      <address>
        <city>Saint Leonards-on-Sea</city>
        <zip>TN37 7PT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Salford Royal NHS Foundation Trust</name>
      <address>
        <city>Salford</city>
        <zip>M6 8HD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Sheffield Children's NHS Foundation Trust</name>
      <address>
        <city>Sheffield</city>
        <zip>S10 2TH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Shrewsbury and Telford Hospital NHS Trust</name>
      <address>
        <city>Shrewsbury</city>
        <zip>SY3 8XQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Hospital Southampton NHS Foundation Trust</name>
      <address>
        <city>Southampton</city>
        <zip>SO16 6YD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Stockport NHS Foundation Trust</name>
      <address>
        <city>Stockport</city>
        <zip>SK2 7JE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>South Tyneside and Sunderland NHS Foundation Trust</name>
      <address>
        <city>Sunderland</city>
        <zip>SR4 7TP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Wirral University Teaching Hospitals NHS Foundation Trust</name>
      <address>
        <city>Wirral</city>
        <zip>CH49 5PE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>February 26, 2018</study_first_submitted>
  <study_first_submitted_qc>March 7, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 14, 2018</study_first_posted>
  <last_update_submitted>September 7, 2020</last_update_submitted>
  <last_update_submitted_qc>September 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Recurrent respiratory papillomatosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Tract Infections</mesh_term>
    <mesh_term>Papillomavirus Infections</mesh_term>
    <mesh_term>Papilloma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Interferons</mesh_term>
    <mesh_term>Acyclovir</mesh_term>
    <mesh_term>Cidofovir</mesh_term>
    <mesh_term>Interferon-alpha</mesh_term>
    <mesh_term>Artemisinins</mesh_term>
    <mesh_term>Celecoxib</mesh_term>
    <mesh_term>Bevacizumab</mesh_term>
    <mesh_term>Methotrexate</mesh_term>
    <mesh_term>Indole-3-carbinol</mesh_term>
    <mesh_term>Isotretinoin</mesh_term>
    <mesh_term>Cimetidine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Patients will be informed that all data collected will be used for research purposes, no patient identifiable information will be shared with external parties for commercial purposes, patient identifiable information will only be accessible by clinicians at their treating organisation, pseudonymised data will be accessed by study analysts, and that only anonymised high-level aggregate data will be shared with other centres to update participating centres of study progress and data completeness issues. Patients will also be informed that any external researchers requesting data from the registry will be required to submit a formal application form and evidence of appropriate ethical approvals in place for review by the Steering Group. If approval is given, only anonymised data will be shared for the purposes of external research studies.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

